Nexalin Technology (NXL) announced that the Company received notice from The Nasdaq Stock Market on October 31, 2024, notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement under Nasdaq Rule 5550(a)(2).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NXL:
- Nexalin announces study on AD, DIFS published in Journal of Alzheimer’s Disease
- Nexalin announced planned clinical trial utilizing Gen-3 Halo headset
- Nexalin Technology announces results from trial using its DIFS technology
- Nexalin appoints Carolyn Shelton as SVP, clinical, quality, regulatory affairs
- Nexalin Technology initiated with a Buy at Maxim